Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial.
Ashenafi Shumey CherkosSylvia M LaCourseDaniel A EnquobahrieJaclyn N EscuderoJerphason MechaDaniel MatemoJohn KinuthiaSarah J IribarrenGrace C John-StewartPublished in: PloS one (2024)
IPT administered to HEU infants did not significantly impact growth outcomes in the first two years of life.